Loading clinical trials...
Loading clinical trials...
Patient PReference, Efficacy, and SaFety of an Intracanalicular DExamenthasone InseRt comparEd to Topical PrednisoloNe in PatienTs UndergoIng SequentiAl PhacoemuLsification With Intraocular Lens Surgery OR Combined Phacoemulsification With IOL and a Minimally Invasive Glaucoma Surgery (MIGS)
Conditions
Interventions
Dextenza 0.4Mg Ophthalmic Insert
Prednisolone Acetate 1% Ophthalmic Suspension [PRED FORTE]
Start Date
November 1, 2020
Primary Completion Date
November 1, 2021
Completion Date
November 1, 2021
Last Updated
November 17, 2021
NCT07362043
NCT06492538
NCT07178639
NCT07154147
NCT07317661
NCT07288086
Lead Sponsor
Duke University
Collaborators
Data Source & Attribution
This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.
Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.
Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.
View ClinicalTrials.gov Terms and Conditions